Author

I. Rosado-Sanchez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. Boardman· 1 shared E. Ruiz-Mateos· 1 shared G. Raimondi· 1 shared I. Herrero-Fernandez· 1 shared K. Salim· 1 shared L. Tarancon-Diez· 1 shared M. d. C. Lozano· 1 shared M. d. M. Pozo-Balado· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

D. Boardman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integration of exogenous and endogenous co-stimulatory signals by CAR-Tregs

I. Rosado-Sanchez, M. Haque, K. Salim, M. Speck, V. Fung, D. Boardman, M. Mojibian, G. Raimondi, M. K. Levings

This study compares CAR-Treg function with different co-stimulatory domains, finding in vivo equivalence between CARs with and without CD28 despite in vitro differences.

bioRxiv · Nov 10, 2022 · PreprintImmunology

Improved CD4 T-cell profile and inflammatory levels in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.

I. Herrero-Fernandez, I. Rosado-Sanchez, M. Genebat, L. Tarancon-Diez, M. d. M. Rodriguez-Mendez, M. d. M. Pozo-Balado, M. d. C. Lozano, E. Ruiz-Mateos, M. Leal, Y. M. Pacheco

The paper examines how maraviroc-containing therapy affects CD4 T-cell profiles and inflammation in HIV patients, linking these factors to improved HBV vaccine response.

bioRxiv · Apr 10, 2018Immunology